GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Doximity Inc (NYSE:DOCS) » Definitions » 5-Year RORE %

DOCS (Doximity) 5-Year RORE % : 34.93% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Doximity 5-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Doximity's 5-Year RORE % for the quarter that ended in Sep. 2024 was 34.93%.

The industry rank for Doximity's 5-Year RORE % or its related term are showing as below:

DOCS's 5-Year RORE % is ranked better than
77.55% of 481 companies
in the Healthcare Providers & Services industry
Industry Median: 6.71 vs DOCS: 34.93

Doximity 5-Year RORE % Historical Data

The historical data trend for Doximity's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Doximity 5-Year RORE % Chart

Doximity Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
5-Year RORE %
Get a 7-Day Free Trial - - - - -

Doximity Quarterly Data
Mar19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
5-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 34.93

Competitive Comparison of Doximity's 5-Year RORE %

For the Health Information Services subindustry, Doximity's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Doximity's 5-Year RORE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Doximity's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where Doximity's 5-Year RORE % falls into.



Doximity 5-Year RORE % Calculation

Doximity's 5-Year RORE % for the quarter that ended in Sep. 2024 is calculated as:

5-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 5-year -Cumulative Dividends per Share for 5-year )
=( 0.87-0.01 )/( 2.462-0 )
=0.86/2.462
=34.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2024 and 5-year before.


Doximity  (NYSE:DOCS) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Doximity 5-Year RORE % Related Terms

Thank you for viewing the detailed overview of Doximity's 5-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Doximity Business Description

Traded in Other Exchanges
N/A
Address
500 3rd Street, Suite 510, San Francisco, CA, USA, 94107
Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.
Executives
Anna Bryson officer: Chief Financial Officer C/O DOXIMITY, INC., 500 3RD STREET SUITE 510, SAN FRANCISCO CA 94107
Kira Scherer Wampler director C/O DOXIMITY, INC., 500 3RD STREET, SUITE 510, SAN FRANCISCO CA 94107
Timothy S Cabral director C/O VEEVA SYSTEMS INC., 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Yang Watkin Phoebe L. director C/O DOXIMITY, INC., 500 THIRD STREET, SAN FRANCISCO CA 94107
Craig Overpeck officer: See Remarks C/O DOXIMITY, INC., 500 THIRD STREET, SUITE 510, SAN FRANCISCO CA 94107
Jeffrey Tangney director, 10 percent owner, officer: Chief Executive Officer C/O DOXIMITY, INC., 500 3RD STREET SUITE 510, SAN FRANCISCO CA 94107
Paul W. Jorgensen officer: Chief Revenue Officer 500 THIRD STREET, SUITE 510, SAN FRANCISCO CA 94107
Gilbert H Kliman director, 10 percent owner C/O INTERWEST PARTNERS, 467 FIRST STREET SUITE 201, LOS ALTOS CA 94022
Emergence Capital Partners Ii Lp 10 percent owner 160 BOVET ROAD, SAN MATEO CA 94402
Emergence Equity Partners Ii, L.p. 10 percent owner 160 BOVET ROAD, SUITE 300, SAN MATEO CA 94402
Emergence Gp Partners, Llc 10 percent owner PIER 5, THE EMBARCADERO, STE 102, SAN FRANCISCO CA 94111-2094
Kevin Spain director C/O EMERGENCE CAPITAL, 160 BOVET ROAD, STE. 300, SAN MATEO CA 94402
Emergence Capital Opportunity I, L.p. 10 percent owner 160 BOVET ROAD, SUITE 300, SAN MATEO CA 94402
Emergence Equity Partners Vi, L.p. 10 percent owner C/O EMERGENCE CAPITAL PARTNERS, 160 BOVET ROAD, SUITE 300 CA SAN MATEO
Regina M. Benjamin director 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453